PMS · Equity · Thematic
Valcreate Lifesciences and Specialty Opportunities
Fund size₹19 Cr
Alpha (3Y)11.02%
3Y return19.34%
Fund age3 yrs 6 mo
Fund Manager
Returns: How it has done
| Scheme / Benchmark | YTD | 1Y | 2Y | 3Y | 5Y | Since inception |
|---|---|---|---|---|---|---|
| Valcreate Lifesciences and Specialty Opportunities | — | 21.71% | 9.77% | 19.34% | — | 19.34% |
| Nifty 500 | −8.38% | 4.72% | −0.11% | 12.09% | — | 14.07% |
| Excess over benchmark | — | 16.99% | 9.88% | 7.25% | — | 5.27% |
Returns up to one year are absolute; two years and above are annualised (CAGR). YTD is calendar-year-to-date.
Risk : What you take on to earn the return
Volatility
20.72%
Benchmark approx 14.72%
A standard deviation reflecting historical swings.
Sensitivity
0.89
Beta vs benchmark 1.00 · 11% less reactive
How strongly the scheme moves with the index.
Risk-reward
0.85
Sharpe
Excess return gained per unit of volatility.
Capture ratio
103 / 33
Upside / Downside Capture
Share of market gains captured versus losses absorbed.
Portfolio Details : Where the money actually sits
Avg market cap
₹58,982 Cr
Asset class
Equity
Top 5 holdings
Sharda Cropchem Ltd11.13%
Kwality Pharmaceuticals Ltd5.72%
Sumitomo Chemical India Ltd5.72%
Vinati Organics Ltd5.51%
Rallis India Ltd5.34%
Fees
A fixed plan is cheaper when returns are strong. A performance plan costs less in lean years and shares the upside only when the fund beats a hurdle. Both cost the same at a 15.00% gross return.
FixedPlan A · SimpleFixed Management Fee2.50% / yr
Performance FeeNone
Hurdle RateNot applicable
VariablePlan B · Shared upsideFixed Management Fee1.50% / yr
Performance Fee20% of profit
Hurdle RateAbove 10%
No exit load. Lock-in: Nil.
Let's start a
conversation
conversation
- Compare this PMS against 3,000+ others with our research desk
- Build a long-term portfolio around your goals, not a one-off buy
- Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.